Abridge Announces Strategic Partnerships with Nvidia and Eli Lilly to Expand AI Healthcare Platform
Abridge, an AI healthcare startup, announced strategic investments and partnerships with pharmaceutical giant Eli Lilly and chipmaker Nvidia on Thursday. The company is developing an AI-native clinician intelligence platform that documents patient-doctor conversations and supports clinical decision-making, billing, and pharmaceutical trial screening across 300+ health systems. The partnerships position Abridge to compete in a rapidly growing ambient clinical intelligence market projected to reach $56.61 billion by 2035.
Abridge announced major partnerships with Eli Lilly and Nvidia as it expands its AI platform for healthcare. The startup's technology captures real-time patient-clinician conversations and automatically generates clinical notes, billing codes, and patient summaries. Eli Lilly made a strategic investment in the company, while Nvidia is co-developing what it calls the first foundation model purpose-built for clinical conversations—distinct from general large language models adapted for medicine. Abridge's platform is already deployed across more than 300 health systems including Northwestern Medicine, Emory Healthcare, and Johns Hopkins, supporting over 100 million clinical conversations annually. The company has raised approximately $1.1 billion to date, with its most recent Series E extension in April 2026 valuing it at $5.3 billion. These partnerships align with both companies' broader AI ambitions: Eli Lilly is building an AI supercomputer and needs patient pipelines for clinical trial enrollment, while Nvidia is expanding its healthcare AI ecosystem.
How coverage differed
Fortune provides significantly more detail on Abridge's business model, competitive positioning, and market projections, while STAT News emphasizes the partnership announcements themselves. WSJ's exclusive framing suggests breaking news, though the other sources provide more comprehensive context about what the partnerships entail.
What different sources said
Related
SpaceX Launches 24 Starlink Satellites as Company Prepares for IPO
SpaceX launched 24 Starlink satellites from Vandenberg Space Force Base in California on June 11, 2026, with the first-stage booster completing its 34th mission. The launch occurred during the same week as SpaceX's highly anticipated IPO on NASDAQ, which has drawn over $100 billion in retail orders. The mission increased the Starlink megaconstellation to more than 10,600 satellites, marking SpaceX's 67th Falcon 9 launch of the year.
SpaceX's First Employee Tom Mueller Reflects on Company's Historic IPO
Tom Mueller, SpaceX's first employee and head of propulsion research, praised the company's upcoming initial public offering as validation of its mission to make space exploration affordable. Mueller met Elon Musk through an amateur rocket club and joined SpaceX in 2002, helping develop the Falcon 9 rocket engines. The IPO represents a milestone for the space industry and could make Musk the world's first trillionaire.
AI Governance Gaps Emerge Across Government and Private Sector
Australian government agencies have largely failed to meet transparency deadlines for disclosing their AI use, with only 43% meeting a February 2025 deadline, while separately, 90% of security leaders report concerns about AI-generated code outpacing security oversight mechanisms. These failures highlight systemic challenges in regulating rapidly evolving AI technology across both public and private sectors. The gaps underscore broader questions about whether self-regulation and existing frameworks can adequately manage AI risks as adoption accelerates.